A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026

This Medical News article is an interview with Rita Kalyani, MD, MHS, the American Diabetes Association’s chief scientific and medical officer and a professor of medicine at Johns Hopkins University School of Medicine, about research presented at the organization’s annual Scientific Sessions.

Authors

Publication Details

Journal
JAMA
Published
2026-06-18
DOI
https://doi.org/10.1001/jama.2026.7591
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026

Jennifer Abbasi
JAMA
Diabetes Treatment and Management
article

A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026

Jennifer Abbasi
article en

Abstract

This Medical News article is an interview with Rita Kalyani, MD, MHS, the American Diabetes Association’s chief scientific and medical officer and a professor of medicine at Johns Hopkins University School of Medicine, about research presented at the organization’s annual Scientific Sessions.

JAMA
Openalex Percentile: Top 7%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.